Descriptions:
Term | description type | Language/acceptability | Language/acceptability | Case significance |
---|---|---|---|---|
Product containing [substance] in [dose form] (medicinal product form) | FSN | us:P | gb:P | ci |
[substance] in [dose form] | SYN | us:P | gb:P | ci |
Product containing [substance] in [dose form] | SYN | us: A | gb:A | ci |
Concept model:
Attribute | Value | role group number | ||||
---|---|---|---|---|---|---|
|
| 0 | ||||
|
| 0 | ||||
|
| 0 |
Definition status:
Scg expression |
---|
900000000000073002|Defined (core metadata concept)| |
Rules for description generation:
- Remove the semantic tag, e.g. (medicinal product)
- The FSN should align with the FSN for the concept in the Substance hierarchy that is selected to represent the active ingredient
- The PT should align with the Preferred Term for the concept in the Substance hierarchy that is selected to represent the active ingredient
- (substance)
- A Preferred Term (PT) for both US and GB dialect as per the substance concept terming must be added where there are US and GB spelling variations (language acceptability P/A)
Align case sensitivity with substance term for FSN (ci or cI) and PT (ci, CS or cI)
Synonyms corresponding to the FSN are required for all concepts